Bernstein analyst Chad Dillard maintained a Hold rating on Caterpillar (CAT – Research Report) yesterday and set a price target of $360.00. The ...

A set of 5844 free MIT-licensed high-quality SVG icons for you to use in your web projects. Each icon is designed on a 24x24 grid and a 2px stroke. If you load an icon as an image, you can modify its ...

HHS told the Sec­ond Cir­cuit that Boehringer In­gel­heim’s vol­un­tary par­tic­i­pa­tion in Medicare ne­go­ti­a­tions “un­der­mines” its le­gal chal­lenge to the process.

Zeit Aktuelle Nachrichten 17.01. Boehringer drug for brain fog in schizophrenia fails trial 16.01. Boehringer's phase 3 schizophrenia program misses primary goal 16.01. Boehringer Ingelheim ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

Scientists identified the tiny species of cat from a fossilized jawbone, which could date back as far as 300,000 years ago. When you purchase through links on our site, we may earn an affiliate ...

Racking up over 16 million views on TikTok, the footage, shared by @mimi_moew1, shows the cat's owner picking up the tabby by the scruff of its neck and turning the feline to face the camera.

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.

On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford ...

Under a new licensing pact, Synaffix will grant Boehringer Ingelheim access to its bespoke ADC technologies for an "agreed but undisclosed number of targets." The first target was decided by the ...